Rett syndrome and long-term disorder profile

American Journal of Medical Genetics, Part A

Volumn 149, Issue 2, 2009, Pages 199-205

  Smeets, Eric E J ^a,b   Chenault, Mickey ^c   Curfs, Leopold M G ^c   Schrander Stumpel, Connie T R M ^c   Frijns, Jean Pierre ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Disorder profile; MECP2; Rett syndrome

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ADOLESCENT; ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RETT SYNDROME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATA COLLECTION; DISEASE PROGRESSION; FEMALE; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MIDDLE AGED; MUTATION, MISSENSE; RETT SYNDROME; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 59849090408     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32491     Document Type: Article

References (18)

1. Amir R, Van den Veyer I, Wan M, Tran C, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MeCP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188.
2. Amir R, Van den Veyer I, Schultz R, Malicki D, Tran C, Dahle E, Philippi A, Timar L, Percy A, Motil K, Lichtarge O, Smith E, Glaze D, Zoghbi H. 2000. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 7:670-679.
3. Cheadle J, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clark A. 2000. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and localisation. Hum Mol Genet 9:1119-1129.
4. Colvin L, Leonard H, de Klerk N, Davis M, Weaving L, Williamson S, Christodoulou J. 2004. Refining the phenotype of common mutations in Rett syndrome. J Med Genet 41:25-30.
5. Hagberg B, Hanefeld F, Percy A, Skjeldal O. 2002. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 6:293-297.
6. Hagberg B, Erlandsson A, Kyllerman M, Larsson G. 2003. Odd MECP2-mutated Rett variant-long-term follow-up profile to age 25. Eur J Paediatr Neurol 7:417-421.
7. Hoffbuhr K, Devaney J, LaFleur B, Sirianni N, Scacheri C, Giron J, Schuette J, Innis J, Marino M, Philippart M, Narayanan V, Umansky R, Kronn D, Hoffman E, Naidu S. 2001. MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 56:1486-1495.
8. Huppke P, Laccone F, Krämer N, Engel W, Hanefeld F. 2000. Rett syndrome: Analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Gen 9:1369-1375.
9. Huppke P, Held M, Hanefeld F, Engel W, Laccone F. 2002. Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics 33:63-68.
10. Kerr A, Nomura Y, Armstrong D, Anvret M, Belichenko P, Budden S, Cass H, Christodoulou J, Clarke A, Ellaway C, d'Esposito M, Francke U, Hulten M, Julu P, Leonard H, Naidu S, Schanen C, Webb T, Witt-Engerström I, Yamashita Y, Segawa M. 2001. Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev 23:208-211.
11. Leonard H, Colvin L, Christodoulou J, Schiavello T, Weaving L, Williamson S, Davis M, Ravine D, Fyfe S, de Klerk N, Matsuishi T, Kondo I, Clarke A, Hackwell S, Yamashita Y. 2003. Patients with the R133C mutation: Is their phenotype different from Rett syndrome patients with other mutations? J Med Genet 40:e53.
12. Monros E, Armstrong J, Aibar E, Poo P, Canos I, Pineda M. 2001. Rett syndrome in Spain: Mutation analysis and clinical correlation. Brain Dev 23:251-253.
13. Schollen E, Smeets E, Deflem E, Fryns J-P, Matthijs G. 2003. Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: Implications for routine diagnosis of Rett syndrome. Hum Mutat 22:116-120.
14. Smeets E, Schollen E, Moog U, Matthijs G, Herbergs J, Smeets H, Curfs L, Schrander-Stumpel C, Fryns J-P. 2003. Rett syndrome in adolescent and adult females: Clinical and molecular genetic findings. Am J Med Gen Part A 122A:227-233.
15. Smeets E, Terhal P, Casaer P, Peters A, Midro A, Schollen E, van Roozendaal K, Moog U, Matthijs G, Herbergs J, Smeets H, Curfs L, Schrander-Stumpel C, Fryns JP. 2005. Rett syndrome in females with CTS hot spot deletions: A disorder profile. Am J Med Genet Part A 132A:117-120.
16. Sung Jae Lee S, Wan M, Francke U. 2001. Spectrum of MECP2 mutations in Rett syndrome. Brain Dev 23:S138-S143.
17. Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, Raynaud M, Sperner J, Fryns JP, Schwinger E, Gécz J, Ropers HH, Kalscheuer VM. 2004. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet 75:1149-1154.
18. Zappella M, Meloni I, Longo I, Hayek G, Renieri A. 2001. Preserved speech variants of the Rett syndrome: Molecular and clinical analysis. Am J Med Genet 104:14-22.